BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 30841008)

  • 1. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.
    Pimentel-Nunes P; Libânio D; Marcos-Pinto R; Areia M; Leja M; Esposito G; Garrido M; Kikuste I; Megraud F; Matysiak-Budnik T; Annibale B; Dumonceau JM; Barros R; Fléjou JF; Carneiro F; van Hooft JE; Kuipers EJ; Dinis-Ribeiro M
    Endoscopy; 2019 Apr; 51(4):365-388. PubMed ID: 30841008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).
    Dinis-Ribeiro M; Areia M; de Vries AC; Marcos-Pinto R; Monteiro-Soares M; O'Connor A; Pereira C; Pimentel-Nunes P; Correia R; Ensari A; Dumonceau JM; Machado JC; Macedo G; Malfertheiner P; Matysiak-Budnik T; Megraud F; Miki K; O'Morain C; Peek RM; Ponchon T; Ristimaki A; Rembacken B; Carneiro F; Kuipers EJ; ; ; ;
    Endoscopy; 2012 Jan; 44(1):74-94. PubMed ID: 22198778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).
    Dinis-Ribeiro M; Areia M; de Vries AC; Marcos-Pinto R; Monteiro-Soares M; O'Connor A; Pereira C; Pimentel-Nunes P; Correia R; Ensari A; Dumonceau JM; Machado JC; Macedo G; Malfertheiner P; Matysiak-Budnik T; Megraud F; Miki K; O'Morain C; Peek RM; Ponchon T; Ristimaki A; Rembacken B; Carneiro F; Kuipers EJ; ; ; ; ;
    Virchows Arch; 2012 Jan; 460(1):19-46. PubMed ID: 22190006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [European guideline for the management of precancerous conditions in the stomach and it's application to Japan].
    Haruma K; Kamada T; Murao T; Yamanaka Y; Ohsawa M; Shiotani A; Inoue K
    Nihon Rinsho; 2013 Aug; 71(8):1479-84. PubMed ID: 23967683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.
    Shah SC; Piazuelo MB; Kuipers EJ; Li D
    Gastroenterology; 2021 Oct; 161(4):1325-1332.e7. PubMed ID: 34454714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
    Kapadia CR
    J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and Cdx2 expression.
    Ahn SY; Lee SY; Hong SN; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ; Han HS
    Dig Dis Sci; 2011 Apr; 56(4):1119-26. PubMed ID: 21221798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Precancerous conditions and lesions of the stomach].
    Falt P; Hanousek M; Kundrátová E; Urban O
    Klin Onkol; 2013; 26 Suppl():S22-8. PubMed ID: 24325159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Perspectives in Atrophic Gastritis.
    Lahner E; Conti L; Annibale B; Corleto VD
    Curr Gastroenterol Rep; 2020 Jun; 22(8):38. PubMed ID: 32542467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI].
    Lahner E; Zagari RM; Zullo A; Di Sabatino A; Meggio A; Cesaro P; Lenti MV; Annibale B; Corazza GR
    Dig Liver Dis; 2019 Dec; 51(12):1621-1632. PubMed ID: 31635944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Guidelines on the Management of Patients with Gastric Atrophy: Common Points and Controversies.
    Matysiak-Budnik T; Camargo MC; Piazuelo MB; Leja M
    Dig Dis Sci; 2020 Jul; 65(7):1899-1903. PubMed ID: 32356261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.
    Vukobrat-Bijedić Z; Radović S; Husić-Selimović A; Gornjaković S
    Bosn J Basic Med Sci; 2006 Nov; 6(4):48-53. PubMed ID: 17177650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori-related precancerous lesions in Turkey: a retrospective endoscopic surveillance study.
    Bas B; Dinc B
    Croat Med J; 2020 Aug; 61(4):319-325. PubMed ID: 32881429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
    Wang X; Zhang Q; Han F; Wu Y
    Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
    [No Abstract]   [Full Text] [Related]  

  • 15. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
    Banks M; Graham D; Jansen M; Gotoda T; Coda S; di Pietro M; Uedo N; Bhandari P; Pritchard DM; Kuipers EJ; Rodriguez-Justo M; Novelli MR; Ragunath K; Shepherd N; Dinis-Ribeiro M
    Gut; 2019 Sep; 68(9):1545-1575. PubMed ID: 31278206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
    Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
    Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric precancerous lesions among Nigerians with chronic gastritis.
    Badmos KB; Ojo OS; Olasode BJ; Arigbabu AO
    Niger Postgrad Med J; 2012 Jun; 19(2):92-6. PubMed ID: 22728974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precancerous lesions in the stomach: from biology to clinical patient management.
    Rugge M; Capelle LG; Cappellesso R; Nitti D; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):205-23. PubMed ID: 23809241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
    Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
    Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.